Shah Capital Management has filed its Form 13F-HR, disclosing the firm’s equity securities portfolio as of the close of business on September 30, 2026. The filing, signed by President and Chief Investment Officer Himanshu H. Shah, lists 11 distinct positions held by the firm during the specified period.
The largest holding disclosed in the filing is Novavax Inc. (NASDAQ: NVAX), for which the firm reported ownership of 12,173,481 shares. Following Novavax, the portfolio includes significant positions in Canadian Solar Inc. (NASDAQ: CSIQ), with 909,571 shares, and China Yuchai International Ltd. (NASDAQ: CYD), with 1,320,058 shares.
Other notable positions listed in the filing include Antero Midstream Corp. (NYSE: AM), with 521,713 shares, and Elicio Therapeutics Inc. (NASDAQ: ELIX), with 1,250,000 shares. The firm also holds stakes in Dole plc (NASDAQ: DOL), Novavax, New Oriental Education & Technology Group (NASDAQ: EDU), Tronox Holdings plc (NYSE: TROX), Veon Ltd. (NASDAQ: VEON), and Realogy Holdings Corp. (NYSE: RLGY).
The filing indicates that Shah Capital Management holds all listed positions as a sole beneficial owner.
